PROK
PROKIDNEY CORP.
NASDAQ · Healthcare · Biotechnology · US
$1.91
+6.11%Next report
Analyst consensus
- Next report date
- Nov 9, 2026
- EPS estimate
- -$0.12
- Revenue estimate
- $124.6K
Latest reported
- Last report date
- Aug 10, 2026
- EPS actual
- -$0.15
- EPS estimate
- -$0.14
- Revenue actual
- $150.0K
- Revenue estimate
- $186.3K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -7.9%
- Revenue beats (12Q)
- 1
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 10, 2026 | -$0.14 | -$0.15 | Miss -7.14% | $150.0K |
| May 15, 2026 | -$0.13 | -$0.14 | Miss -7.69% | $226.0K |
| Mar 18, 2026 | -$0.15 | -$0.14 | Beat 4.53% | — |
| Mar 17, 2025 | -$0.14 | -$0.17 | Miss -21.43% | $76.0K |
| Aug 9, 2024 | -$0.17 | -$0.16 | Beat 5.88% | — |
| May 10, 2024 | -$0.25 | -$0.16 | Beat 36.00% | — |
| Mar 21, 2024 | -$0.19 | -$0.09 | Beat 52.63% | $4.5M |
| Nov 14, 2023 | -$0.19 | -$0.18 | Beat 5.26% | — |
| Aug 10, 2023 | -$0.41 | -$0.14 | Beat 65.85% | — |
| May 11, 2023 | -$0.39 | -$0.16 | Beat 58.97% | — |
| Nov 14, 2022 | -$0.05 | -$0.13 | Miss -160.00% | — |
| Aug 12, 2022 | — | -$0.36 | — | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 9, 2026